OTC Products - Worldwide

Worldwide

The OTC Products market worldwide is projected to achieve a revenue of US$368.90bn in 2024.
It is expected to exhibit an annual growth rate (CAGR 2024-2029) of 4.50%, leading to a market volume of US$459.70bn by 2029.
Among all countries, China is anticipated to generate the highest revenue of US$74.91bn in 2024.
When considering the total population, the per-person revenue in 2024 amounts to US$47.60.
The demand for OTC products is growing steadily in countries worldwide, driven by increasing consumer awareness and accessibility.

Key regions: Europe, Australia, United Kingdom, Germany, South Korea

Market

Region

Region comparison

Currency

Analyst Opinion

The OTC Products (Pharmacies) market in worldwide is experiencing significant growth and development.

Customer preferences: Customers in the OTC Products (Pharmacies) market are increasingly seeking convenience and accessibility. They prefer to have easy access to a wide range of products without the need for a prescription. This trend is driven by the desire for self-care and the increasing awareness of the benefits of preventive healthcare. Customers also value competitive pricing and the availability of trusted and reliable brands.

Trends in the market: One of the key trends in the OTC Products (Pharmacies) market is the expansion of product offerings. Pharmacies are diversifying their product portfolios to cater to the changing needs and preferences of customers. This includes the introduction of new and innovative products, such as natural and organic remedies, vitamins and supplements, and personal care items. Pharmacies are also focusing on providing specialized services, such as medication management and health consultations, to enhance the overall customer experience. Another trend in the market is the increasing adoption of e-commerce. Pharmacies are leveraging online platforms to reach a wider customer base and provide convenient shopping options. Online pharmacies offer the convenience of home delivery and easy access to product information and reviews. This trend has been accelerated by the COVID-19 pandemic, as customers have turned to online shopping for their healthcare needs.

Local special circumstances: The OTC Products (Pharmacies) market in each country has its own unique set of circumstances that influence its development. For example, in developed countries with well-established healthcare systems, pharmacies play a significant role in providing accessible and affordable healthcare. In contrast, in developing countries with limited access to healthcare facilities, pharmacies serve as primary points of care and play a crucial role in improving healthcare outcomes. In some countries, regulations and restrictions on the sale of certain OTC products may impact the market. For instance, some countries have stricter regulations on the sale of medications, requiring a prescription for even common OTC drugs. This can limit the growth potential of the OTC Products (Pharmacies) market in those regions.

Underlying macroeconomic factors: The growth of the OTC Products (Pharmacies) market is closely tied to macroeconomic factors such as population growth, urbanization, and income levels. As the global population continues to grow and urbanization increases, the demand for healthcare products and services, including OTC products, is expected to rise. Rising disposable incomes in many countries also contribute to increased spending on healthcare and wellness products. Furthermore, the aging population is driving the demand for OTC products. As people age, they often require more healthcare products and services to manage chronic conditions and maintain their health. This demographic trend is expected to fuel the growth of the OTC Products (Pharmacies) market in the coming years. In conclusion, the OTC Products (Pharmacies) market in worldwide is witnessing significant growth and development. Customer preferences for convenience, accessibility, and competitive pricing are driving the expansion of product offerings and the adoption of e-commerce. Local special circumstances, such as healthcare systems and regulations, vary across countries and impact the market's development. Underlying macroeconomic factors, including population growth, urbanization, and income levels, also play a significant role in shaping the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.